Histological Validation of FDG and PSMA-Targeted PET/CT Imaging in a Rare Tracheal Adenoid Cystic Carcinoma.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Jan 2023
01 Jan 2023
Historique:
entrez:
5
12
2022
pubmed:
6
12
2022
medline:
25
2
2023
Statut:
ppublish
Résumé
Adenoid cystic carcinomas are the second most common entity of tracheal malignancies, which have an overall incidence as low as only 0.2 in 100,000 persons per year. We present the case of a 64-year-old man with a histologically confirmed adenoid cystic carcinoma who sequentially underwent 18F-FDG PET/CT and 68Ga-PSMA-11 PET/CT within 1 day for staging 3 days before surgical resection of the tumor. Immunohistochemistry revealed PSMA expression of the tumor corroborating the PSMA PET findings.
Identifiants
pubmed: 36469074
doi: 10.1097/RLU.0000000000004441
pii: 00003072-202301000-00033
doi:
Substances chimiques
gallium 68 PSMA-11
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Gallium Radioisotopes
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16-e18Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: P.S. received fees as a consultant for Advanced Accelerator Applications. R.S., A.S., D.T., and H.H. have no conflicts of interest to disclose.
Références
Azar T, Abdul-Karim FW, Tucker HM. Adenoid cystic carcinoma of the trachea. Laryngoscope . 1998;108:1297–1300.
Isgoren S, Hekimsoy T, Koroglu E, et al. PET/CT with 68 Ga-PSMA and 18 F-FDG in metastatic adenoid cystic carcinoma: report of 2 cases. Clin Nucl Med . 2022;47:e423–e424.
Klein Nulent TJW, Valstar MH, de Keizer B, et al. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT. Oral Surg Oral Med Oral Pathol Oral Radiol . 2018;125:478–486.
Klein Nulent TJW, van Es RJJ, Krijger GC, et al. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma—a preliminary analysis. Eur J Nucl Med Mol Imaging . 2017;44:1614–1621.
Klein Nulent TJW, van Es RJJ, Willems SM, et al. First experiences with 177 Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer. EJNMMI Res . 2021;11:126.
Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med . 2021;385:1091–1103.
Rischpler C, Beck TI, Okamoto S, et al. (68)Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging. J Nucl Med . 2018;59:1406–1411.
Lang BH, Cowling BJ, Li JY, et al. High false positivity in positron emission tomography is a potential diagnostic pitfall in patients with suspected adrenal metastasis. World J Surg . 2015;39:1902–1908.
Nelson R, Clemenshaw M, Elhelf IAS. 68 Ga-DOTATATE PET/CT scan as a valuable tool for diagnosis and staging of the rare entity of tracheal paragangliomas. Clin Nucl Med . 2022;47:e450–e451.
Datta Gupta S, Arora G, Kumar D, et al. Rare brain metastasis in parotid adenoid cystic carcinoma detected on 68 Ga-PSMA PET/CT. Clin Nucl Med . 2021;46:e561–e562.
Uijen MJM, Weijers JAM, Driessen CML, et al. 68 Ga-prostate-specific membrane antigen-avid malignant pleural effusion in a patient with metastatic adenoid cystic carcinoma and concordance with 18 F-FDG PET/CT. Clin Nucl Med . 2022;47:140–141.
Wu J, Tao Y, Liu Y, et al. 18 F-FDG PET/CT of primary tracheal adenoid cystic carcinoma. Clin Nucl Med . 2021;46:766–767.
Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics . 2003;23:315–340; quiz 533.